Insulin resistance, type 1 and type 2 diabetes, and related complications: current status and future perspective

Affiliations

¹ Department of Physiology, College of Medicine, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK, Canada S7N 5E5.
² Division of Cardiology, Department of Medicine, Henry Ford Heart and Vascular Institute, 2799 West Grand Boulevard, Detroit, MI 48202-2689, USA.
³ Department of Pharmacology, Center for Integrative Medicine, Center for Molecular Medicine (CIMMBA), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.

Editorial

Joseph Fomusi Ndisang et al. J Diabetes Res. 2014.

. 2014:2014:276475.

doi: 10.1155/2014/276475. Epub 2014 Mar 18.

¹ Department of Physiology, College of Medicine, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK, Canada S7N 5E5.
² Division of Cardiology, Department of Medicine, Henry Ford Heart and Vascular Institute, 2799 West Grand Boulevard, Detroit, MI 48202-2689, USA.
³ Department of Pharmacology, Center for Integrative Medicine, Center for Molecular Medicine (CIMMBA), University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.

No abstract available

References

1. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world—a growing challenge. The New England Journal of Medicine. 2007;356(3):213–215. - PubMed
1. WHO. Obesity and overweight. Fact Sheet no. 311 in: World Health Organization, 2006.
1. Mishra M, Ndisang JF. A critical and comprehensive insight on heme oxygenase and related products including carbon monoxide, bilirubin, biliverdin and ferritin in type-1 and type-2 diabetes. Current Pharmaceutical Design. 2013 - PubMed
1. Tiwari S, Ndisang JF. The heme oxygenase system and type-1 diabetes. Current Pharmaceutical Design. 2013 - PubMed
1. Cleland SJ, Fisher BM, Colhoun HM, Sattar N, Petrie JR. Insulin resistance in type 1 diabetes: what is “double diabetes” and what are the risks? Diabetologia. 2013;56(7):1462–1470. - PMC - PubMed